Company / Operating Income
Centessa Pharmaceuticals plc Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$207.7M
FY2025
5-year range
-$374.1M / -$171.3M
FY2021-FY2025
Trend
-3.3%
vs FY2024
Sector context
#144 of 204
Health Care
What the data says
At -$208M, Centessa Pharmaceuticals plc's operating income ranks #144 of 204 in the Health Care sector. Declined from -$171M to -$208M over the past 2 years.
Based on SEC 10-K filings.
-$208M in FY2025.
Declined from -$171M to -$208M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#144 of 204 in Health CareTop 71% of 204This company -$207.7M Sector average $107.7M
▼
-292.8% below sector average
Key checks
Key Insights
- In FY2025, operating income decreased 3.3% year-over-year.
- Ranks #144 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2019.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$207.7M | -3.3% |
| FY2024 | -$201.1M | -17.4% |
| FY2023 | -$171.3M | +19.3% |
| FY2022 | -$212.3M | +43.3% |
| FY2021 | -$374.1M | -3483.2% |
| FY2020 | -$10.4M | -106.6% |
| FY2019 | -$5.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026